ReviewMolecular cancer2019

Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations.

Anqi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.